News
Pfizer has been paying dividends for 35 years and raising them for 14 years. Read more to see whether PFE stock is a buy.
23h
Health and Me on MSNEli Lilly's Experimental GLP-1 Pill Shows Promising Weight LossLilly, known for injectable drugs like Zepbound for obesity and Mounjaro and Trulicity for diabetes, is among several ...
A new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...
Pfizer has encountered many setbacks in its quest to launch a medicine that could rival Wegovy and Zepbound. One of its ...
As tough as it may be to do right now, this is a great time to hold your nose and dive in while yields are as high as they are.
When it comes to oral semaglutide, the OASIS-1 trial showed that it led to a 15.1% reduction in body weight. But this was at ...
Diabetics given the pill called orforglipron lost 16 pounds, or 7.9% of their body weight, over a 40-week period.
Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...
Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 ...
In an hour-long meeting at Eli Lilly and Company’s headquarters in Indianapolis on April 15, the pharmaceutical company’s top ...
Get all latest & breaking news on Hetero Drugs. Watch videos, top stories and articles on Hetero Drugs at moneycontrol.com.
Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results